Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
Clinical trial NCT00075946 · COMPLETED
Trial details
- NCT number
- NCT00075946
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-23
- Primary completion
- 2013-09-01
- Enrollment
- 545
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.